Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05608018 · ClinicalTrials.gov registry record · NA
Preventing Distracted Driving Phase II
A NA study of Distracted Driving, sponsored by Minnesota HealthSolutions.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05608018: Completed NA study of Distracted Driving, sponsored by Minnesota HealthSolutions.
NCT05608018 is a NA study of Distracted Driving that has completed, run by Minnesota HealthSolutions. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05608018, a NA study of Distracted Driving, has completed, sponsored by Minnesota HealthSolutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine the efficacy of a smartphone app in reducing mobile phone use while driving among teens and parents. Prior to sending a message, the smartphone app informs a potential message sender that the recipient is driving.
Primary Outcome
Changes in smartphone communication sent from parent to teen while the teen is driving and changes in smartphone communication sent from teen while the teen is driving. Frequency of smartphone use is recorded by the app among the three app modes. Within-driver smartphone use over the 3-week study period is compared as the app modes change. Smartphone use between driver groups will also be compared.
Conditions Studied
Interventions
- OTHER Intervention Bluetooth
- OTHER Intervention non-Bluetooth
- OTHER Control Bluetooth
- OTHER Control non-Bluetooth
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2024-07-23 |
| Phase | NA |
What the finished NCT05608018 record still lists
NCT05608018 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Distracted Driving appearing as the primary indexed condition, and to 4 interventions - of which Intervention Bluetooth is the first listed.
NCT05608018 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05608018 about?
NCT05608018 is a clinical study titled "Preventing Distracted Driving Phase II". The purpose of the study is to determine the efficacy of a smartphone app in reducing mobile phone use while driving among teens and parents. Prior to sending a message, the smartphone app informs a potential message sender that the recipient is driving.
What is the current status of trial NCT05608018?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2023-06-26. Estimated completion is 2024-07-23.
What conditions does trial NCT05608018 study?
This clinical trial studies the following conditions: Distracted Driving.
What interventions are being tested in trial NCT05608018?
The interventions under investigation include: Intervention Bluetooth (OTHER), Intervention non-Bluetooth (OTHER), Control Bluetooth (OTHER), Control non-Bluetooth (OTHER).
Who is sponsoring clinical trial NCT05608018?
This trial is sponsored by Minnesota HealthSolutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05608018 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Distracted Driving
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05608018's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI